U.S. Allergy Diagnostics And Therapeutics Market Size & Outlook
- Pharmaceuticals
- Respiratory Drugs
- Allergy Diagnostics And Therapeutics Market Outlook
- Respiratory Drugs
Global Market
Related Markets
Ask a question about the allergy diagnostics and therapeutics market
U.S. allergy diagnostics and therapeutics market highlights
- The U.S. allergy diagnostics and therapeutics market generated a revenue of USD 11,596.5 million in 2025 and is expected to reach USD 19,240.3 million by 2033.
- The U.S. market is expected to grow at a CAGR of 6.5% from 2026 to 2033.
- In terms of segment, therapeutics was the largest revenue generating type in 2025.
- Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
Allergy diagnostics and therapeutics market data book summary
| Market revenue in 2025 | USD 11,596.5 million |
| Market revenue in 2033 | USD 19,240.3 million |
| Growth rate | 6.5% (CAGR from 2026 to 2033) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.5% of the global allergy diagnostics and therapeutics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. allergy diagnostics and therapeutics market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 2,539.6 million by 2033.
The allergy diagnostics and therapeutics market is projected to showcase lucrative growth over the forecast period due to increasing prevalence of allergy cases, rising awareness about early diagnosis, and availability of a wide range of therapeutics. Furthermore, rising number of key players focusing on the development of new products, and increasing number of clinical trials in the country are fueling the market growth.
For instance, in October 2022, ARS Pharmaceuticals announced that the U.S. FDA accepted a New Drug Application (NDA) for its neffy nasal epinephrine device for the emergency treatment of anaphylaxis in children and adults. Some of the key players in the market are AbbVie, Inc., Allergy Therapeutics, and Pfizer, Inc.
No credit card required*
Publish Date: Apr 22, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Alcon Inc | View profile | 25,315 | Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, Switzerland, 1214 | www.alcon.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
U.S. Allergy Diagnostics And Therapeutics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Allergy Diagnostics And Therapeutics Market Outlook will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 85.29% in 2025.
Horizon Databook has segmented the U.S. allergy diagnostics and therapeutics market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
The allergy diagnostics and therapeutics market is projected to showcase lucrative growth over the forecast period due to increasing prevalence of allergy cases, rising awareness about early diagnosis, and availability of a wide range of therapeutics. Furthermore, rising number of key players focusing on the development of new products, and increasing number of clinical trials in the country are fueling the market growth.
For instance, in October 2022, ARS Pharmaceuticals announced that the U.S. FDA accepted a New Drug Application (NDA) for its neffy nasal epinephrine device for the emergency treatment of anaphylaxis in children and adults. Some of the key players in the market are AbbVie, Inc., Allergy Therapeutics, and Pfizer, Inc.
- U.S. Allergy Diagnostics And Therapeutics Market Type Outlook (Revenue, USD Million , 2021-2033)
- Diagnostics
- Therapeutics
- U.S. Allergy Diagnostics And Therapeutics Market Allergen Type Outlook (Revenue, USD Million , 2021-2033)
- Food
- Inhaled
- Drug
- Other Allergens
Reasons to subscribe to Allergy Diagnostics And Therapeutics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Allergy Diagnostics And Therapeutics Market Outlook databook
- Our clientele includes a mix of Allergy Diagnostics And Therapeutics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Allergy Diagnostics And Therapeutics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Allergy Diagnostics And Therapeutics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Allergy Diagnostics And Therapeutics Market, 2021-2033 (US$M)
US Type - Allergy Diagnostics And Therapeutics Market Statistics, 2025 - 2033 (US$M)
